BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai CC, Ko WC, Chen CJ, Chen PY, Huang YC, Lee PI, Hsueh PR. COVID-19 vaccines and thrombosis with thrombocytopenia syndrome. Expert Rev Vaccines 2021;:1-9. [PMID: 34176415 DOI: 10.1080/14760584.2021.1949294] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
Number Citing Articles
1 Chen C, Yang L, Chang W, Huang Y, Chiu C, Shih S, Huang C, Huang KA. A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-33146-7] [Reference Citation Analysis]
2 Li LH, Liesenborghs L, Wang L, Lox M, Yakass MB, Jansen S, Rosales Rosas AL, Zhang X, Thibaut HJ, Teuwen D, Neyts J, Delang L, Dallmeier K. Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate. Mol Ther Methods Clin Dev 2022;25:215-24. [PMID: 35313504 DOI: 10.1016/j.omtm.2022.03.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Abdel Moniem A, Radwan MA, Yousef AI. COVID-19 and cardiovascular disease: Manifestations, pathophysiology, vaccination, and long-term implication. Current Medical Research and Opinion. [DOI: 10.1080/03007995.2022.2078081] [Reference Citation Analysis]
4 Pang X, Liu H, He X, Ji T, Zhu Y, Cui Y. Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2. Front Immunol 2021;12:782335. [PMID: 35095856 DOI: 10.3389/fimmu.2021.782335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Huang Z, Su Y, Zhang T, Xia N. A review of the safety and efficacy of current COVID-19 vaccines. Front Med 2022. [PMID: 35122210 DOI: 10.1007/s11684-021-0893-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Ihnatko M, Truchla I, Ihnatková L, Prohászka Z, Lazúrová I. Case Report: A Case of COVID Vaccine-Induced Thrombotic Thrombocytopenia Manifested as Pulmonary Embolism and Hemorrhagia. A First Reported Case From Slovakia. Front Med (Lausanne) 2021;8:789972. [PMID: 35059416 DOI: 10.3389/fmed.2021.789972] [Reference Citation Analysis]
7 Shiri T, Evans M, Talarico CA, Morgan AR, Mussad M, Buck PO, Mcewan P, Strain WD. The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program. Vaccines 2022;10:140. [DOI: 10.3390/vaccines10020140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
8 Sung JC, Liu Y, Wu KC, Choi MC, Ma CH, Lin J, He EIC, Leung DY, Sze ET, Hamied YK, Lam DM, Kwong KW. Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate. Vaccines (Basel) 2021;10:2. [PMID: 35062663 DOI: 10.3390/vaccines10010002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Warkentin TE, Pai M. Editorial on Thaler et al. long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia. Thromb Res 2021 in press. Thromb Res 2021;207:158-60. [PMID: 34757250 DOI: 10.1016/j.thromres.2021.10.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Fenton C, Lamb YN. COVID-19: State of the Vaccination. Drugs Ther Perspect 2021;:1-11. [PMID: 34667427 DOI: 10.1007/s40267-021-00869-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]